Human Complement C3 Deficient Heparin Plasma

• Description:

  Human Complement C3 Deficient Heparin Plasma_x000D_ Catalog number: B2015128_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 1 mL_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Plasma_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: -20° C_x000D_ Keywords: Complement Component 3, Complement Component III, Complement Factor 3_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Burge J, Nicholson-Weller A, Austen KF. Isolation of C4-binding protein from guinea pig plasma and demonstration of its function as a control protein of the classical complement pathway C3 convertase J Immunol. 1981 Jan;126(1):232-5._x000D_ 2: Cheng ZZ, Hellwage J, Seeberger H, Zipfel PF, Meri S, Jokiranta TS. Comparison of surface recognition and C3b binding properties of mouse and human complement factor H Mol Immunol. 2006 Mar;43(7):972-9._x000D_ 3: Sahu SK, Ozantürk AN, Kulkarni DH, Ma L, Barve RA, Dannull L, Lu A, Starick M, McPhatter J, Garnica L, Sanfillipo-Burchman M, Kunen J, Wu X, Gelman AE, Brody SL, Atkinson JP, Kulkarni HS. Lung epithelial cell-derived C3 protects against pneumonia-induced lung injury Sci Immunol. 2023 Feb 3;8(80):eabp9547._x000D_ 4: Chen P, Yu G, Zhang X, Xie X, Wang J, Shi S, Liu L, Lv J, Zhang H. Plasma Galactose-Deficient IgA1 and C3 and CKD Progression in IgA Nephropathy Clin J Am Soc Nephrol. 2019 Oct 7;14(10):1458-1465._x000D_ 5: Zhang W, Wang G, Wang Y, Jin Y, Zhao L, Xiong Q, Zhang L, Mou L, Li R, Yang H, Dai Y. Generation of complement protein C3 deficient pigs by CRISPR/Cas9-mediated gene targeting Sci Rep. 2017 Jul 10;7(1):5009._x000D_ 6: Servais A, Noël LH, Frémeaux-Bacchi V, Lesavre P. C3 glomerulopathy Contrib Nephrol. 2013;181:185-93._x000D_ 7: Durey MA, Sinha A, Togarsimalemath SK, Bagga A. Anti-complement-factor H-associated glomerulopathies Nat Rev Nephrol. 2016 Sep;12(9):563-78._x000D_ 8: Márquez-Tirado B, Gutiérrez-Tenorio J, Tortajada A, Lucientes Continente L, Caravaca-Fontán F, Malik TH, Roldán Montero R, Elías S, Saiz Gonzalez A, Fernández-Juarez G, Sánchez-Corral P, Pickering MC, Praga M, Rodríguez de Córdoba S, Goicoechea de Jorge E. Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy J Am Soc Nephrol. 2022 Jun;33(6):1137-1153._x000D_ 9: Fakhouri F, de Jorge EG, Brune F, Azam P, Cook HT, Pickering MC. Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice Kidney Int. 2010 Aug;78(3):279-86._x000D_ 10: Lenhart-Pendergrass PM, Malcolm KC, Wheeler E, Rysavy NM, Poch K, Caceres S, Calhoun KM, Martiniano SL, Nick JA. Deficient Complement Opsonization Impairs Mycobacterium avium Killing by Neutrophils in Cystic Fibrosis Microbiol Spectr. 2023 Feb 14;11(1):e0327922. _x000D_ _x000D_ Products Related to Human Complement C3 Deficient Heparin Plasma can be found at Biofluids

• Short Description:

  Catalog Number: B2015128 (1 mL)_x000D_ Human Complement C3 Deficient Heparin Plasma is a high quality Human Complement C3 Deficient Plasma (Heparin). This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5